Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There are people on this board who were into CYDY such as myself who found their way out.
I wised up. Later I posted a few messages on the CYDY board asking them to reconsider or in the alternative to invest in HGEN as a hedge. I got numerous private replies that were not complimentary and worse. Its a cult like atmosphere there.
Right here.
Nomis is still selling. Its a continual drag on upward movement that is unrelated to the company's progress or expectations. And as such does not make sense in the big picture of things except to lock in profits without risk. Playing for singles and not homeruns.
Its great to have a time frame given as to these events. It makes it so much easier to handle the dips and waiting,
How about that as before Nomis continues to sell off its position making shares easy to come by.
Or that retail/others believes demand for therapeutics will be low because of vaccines and looming herd immunity.
Or that there has been insufficient public awareness of what has been achieved and the tremendous potential the drug has. This is effected by so many companies throwing their hats into the covid ring.
All speculation on my part I do not know. Perhaps a combination of them all.
Hard to understand that days away from an anticipated announced EAU application that you would expose yourself to losing much more than you could gain.
Fidelity says that they only loan out your shares with your permission and that you can earn money by agreeing to do so.
Fidelity will not let you do this. Maximum is 50% above SP.
Thanks for saying this. Feels like a sucker punch, would like an explanation why it was necessary.
If you go over to the CYDY boards and provoke them, then they come over here to retaliate.
I want to focus on our data and what happens from there.
I do not feel your continued love for CYDY. I was a heavy investor in CYDY
made some money off the pumps until I realized how mgt was distorting data and its opportunities. Realized that it was unsafe to continue.
I learned about HGEN as a resulting of bashing HGEN by CYDY enthusiasts. Over a period of time I came to realize that HGEN was the antithesis of CYDY. I took every single dollar I had invested in CYDY and switched it into HGEN.
I had emptied my account on HGEN but had a few dollars left. Put in a buy for 1 share some time ago but didn't think we would go that low pre data release Forgot about it. Yesterday's plunge tripped the buy and I increased my HGEN empire by 1 share.
Never know what's going to happen.
Not much I can do about this manipulation except to hold on to my shares.
Agree nuts and salty balls too.
Who had that many shares to sell in one clump other than Nomis?
And Nomis has been continually selling with all the good news coming in previously.
And almost immediately after Nomis is under !0% this huge transaction occurs.
Simplest explanation maybe Nomis wanted to lock in their very substantial profits without risk of the readout.
But who was the buyer.
Any possibility its the first stage of a buyout and that's why it wasn't dark pool so Nomis wouldn't know who the buyer was?
My imagination is running wild trying to make sense of this.
Maybe the simplest explanation is the best.
Glad you weren't burned here. My heart would have been going so fast it would have been hard to think.
That's a good question. Friggin manipulation. I feel like I'm a small boat surrounded by twenty foot waves.
Looks like that doesn't it. Two big fish agree to exchange shares at certain price and spend last few days driving price down.
Nomis is only one with that many shares to sell.
Twits say 3 million shares
One of the things mentioned by Janet Woodcock at the AMA presentation was with so many clinical trials going on regarding covid that there was competition for patients.
As mentioned only 5% of trials are considered adequately powered and randomized for FDA purposes.
Listened to the AMA webinar on therapeutics with three FDA speakers including Janet Woodcock.
Tghey advised that of the nearly 3,000 clinical trials world wide related to covid only 5% could be considered adequately powered and randomized.
That the U.S. did not have a strong clinical trial system when the pandemic hit
That many trials did not incorporate diverse populations.
That too many trials were looking at hydroxychloroquine.
Mixed results with convalescent plasma.
Reviewed current drugs approved for covid and their niche and safety concerns.
Did not specifically discuss HGEN or other drugs still in trials.
Janet Woodcock guest at AMA webinar Wednesday to discuss therapeutics and clinical trials. HGEN may come up.
https://www.ama-assn.org/delivering-care/public-health/covid-19-webinar-therapeutics-use
What;s wrong with you? The drug failed in both CD10 and CD 12.
Imagine this and imagine that, bullocks, deal with reality please.
You need new and better mgt that can design trials that have a better chance of succeeding.
Right now what the company is accomplishing is distortion, creating false hopes and lining its own pockets.
There are so many other better and safer biotechs out there that people can invest their money in than this one.
If you want to make things happen invest in other biotechs with better reputations and mgt. There are so many other safer places to invest your money.
CYDY has never delivered on anything. It strings investors along in hopes that you think it actually did something.
If you held the CEO and board accountable for trial design and trial results, you might eventually have something that works in the future.
Why would you bother Dr. Woodcock when CYDY failed on all endpoints.
These people have other work to do.
Grow up! Design a new trial that isn't flawed and see if you can hit new endpoints.
The FDA doesn't want to be bothered with CYDY until it can delivered meaningful data.
Always spinning and distorting to the end.
AF reports all 5 end points missed
I hope this is the storm before the calm. The calm where are main concern will be when do we sell, after HGEN starts its dramatic upward move.
In disclosure I am a former CYDY investor and I made money on the stock.
I defended the company on message boards against attacks from people such as Adam F.
But one day I woke up and realized that NP was giving me a bunch of hogwash designed to keep me in and that I was being manipulated.
One point I would ask you to consider is that CYDY going alone is not by choice but rather a result of CYDY's reputation and lack of accomplishments.
Well this is something. Usually stocks go up before a data release.
If something is cooking hopefully its not my rear end.
Thats true to a certain degree but if the data were good the company would be receiving tons of federal support and partnership/buyout offers that would negate the need to sell hundreds of millions of new shares.
Money would be falling from the sky.
We want companies to develop treatments for covid. But why not invest in companies that have better reputations and management. There are hundreds of other companies working on treatments for covid.
The fact that CYDY has gone into a hole to hide its data leads me to believe they failed on the trial and are not being upfront with its shareholders.
The best scenario I can come up with is that the company failed on the endpoints and NP is trying to use some data on a subset to argue to FDA and others that the drug be approved.
Why does CYDY need to register to sell more shares to finance itself if the results were good?
Because they weren't.
The company has continued to hide the data and results from its shareholders for one reason.
There was massive problem with the HIV BLA if it takes a whole year for it to be refiled not the quick fix you were led to believe.
Of course in NP language first half means second half and two weeks means two months or never.
CYDY based on last quarter's burn and the coming end of quarter is broke.
Some further dilution is inevitable. Someone needs to keep paying NP's huge undeserved salary.
You are right other than to mention that they have a number of fill and finish service agreements, he blew right by it.
Guess he wanted the stage to pump his own products.
He sounded very positive though about "that product" and I do not think it was meant as a slight or anything.
Well said. Out of our hands I will not give up any shares until data released.